“…Goldberg (1964), Sj6qvist (1965) and other workers who have reported interactions between monoamine oxidase inhibitors and sympathomimetic amines base their explanations on the following sequence of events: when intraneuronal monoamine oxidase is inhibited the noradrenaline stores increase and hence larger amounts of noradrenaline will be liberated by noradrenaline-releasing drugs. Monoamine oxidase inhibitors have been reported to elevate the content of catecholamines in the brain of rat, rabbit, mouse, monkey and man (Bums & Shore, 1961;Crout et al, 1961;Wiegand & Perry, 1961;Maling, Highman & Spector, 1962;Ganrot, Rosengren & Gottfries, 1962;Spector, 1963) and in the heart of rat, guinea-pig and dog (Pletscher & Pellmont, 1958;Crout et a)., 1961;Kopin, 1964), but no significant change in the catecholamine level has been found in the brain of cat and dog (Vogt, 1954;Spector, Shore & Brodie, 1960;Burns & Shore, 1961;Maling et al, 1962) or in rabbit and mouse heart (Spector et al, 1960;Goldberg & Shideman, 1962). The atria from nialamide treated kittens exhibited diminished inotropic activity in response to direct and indirectly acting sympathomimetics.…”